SOUTH SAN FRANCISCO, Calif., July 16 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc., (Nasdaq: MGRM) announced that it will hold a conference
call on Tuesday, July 29, 2008 at 4:30 p.m. (Eastern Time) to discuss
second quarter 2008 financial results. The call will be hosted by Mr.
William D. Young, Chairman and CEO of Monogram.
To participate in the live teleconference, please call (877) 675-4748,
or (719) 325-4848 for international callers, fifteen minutes before the
conference begins. Live audio of the call will be simultaneously broadcast
over the Internet and will be available to members of the news media,
investors and the general public. Following the live broadcast, a replay of
the call will also be available beginning at 9:30 p.m. (Eastern Time) at
(888) 203-1112, or (719) 457-0820 for international callers, until 11:59
p.m. (Eastern Time) on Tuesday, August 12, 2008. The replay passcode is
3249168. Access to live and archived audio of the conference call will be
available by following the appropriate links at http://www.monogrambio.com and
clicking on the Investor Relations link.
The information provided on the teleconference is only accurate at the
time of the conference call, and Monogram will take no responsibility for
providing updated information except as required by law.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering,
developing and marketing innovative products to guide and improve treatment
of serious infectious diseases and cancer. The Company's products are
designed to help doctors optimize treatment regimens for their patients
that lead to better outcomes and reduced costs. The Company's technology is
also being used by numerous biopharmaceutical companies to develop new and
improved antiviral therapeutics and vaccines as well as targeted cancer
therapeutics. More information about the Company and its technology can be
found on its web site at http://www.monogrambio.com.
Contacts:
Alfred G. Merriweather Jeremiah Hall
Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700
amerriweather@monogrambio.com jeremiah.hall@fkhealth.com
SOURCE Monogram Biosciences, Inc.
 back to top
Related links:
http://www.monogrambio.com
CONTACT:
Alfred G. Merriweather, Chief Financial
Officer of Monogram Biosciences, Inc., +1-650-624-4576,
amerriweather@monogrambio.com; or Jeremiah Hall of Feinstein Kean
Healthcare, +1-415-677-2700, jeremiah.hall@fkhealth.com
|
